Related Experiment Video
Updated: Nov 9, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Patients with Early-Onset Colorectal Cancer Have an Increased Risk of Second Primary Malignancy
Amelie Tiritilli1, Cynthia Ko2
1Division of Gastroenterology, Department of Medicine, School of Medicine, University of Washington, Box 356424, Seattle, WA, USA. act11@uw.edu.
Individuals diagnosed with early-onset colorectal cancer (eoCRC) face a significantly higher risk of developing a second primary malignancy (SPM). This increased risk is most pronounced within five years of the initial diagnosis and appears to be rising over time.
Area of Science:
- Oncology
- Epidemiology
- Cancer Research
Background:
- Colorectal cancer (CRC) incidence is decreasing overall in the USA.
- Early-onset CRC (eoCRC) incidence in individuals under 50 is increasing.
- The risk of second primary malignancy (SPM) in eoCRC patients is not well understood.
Purpose of the Study:
- To investigate the risk of SPM in patients with eoCRC.
- To compare the SPM risk in eoCRC patients versus late-onset CRC (loCRC) patients.
- To identify specific cancer types and risk factors associated with SPM after eoCRC.
Main Methods:
- Utilized data from the Surveillance, Epidemiology, and End Results (SEER) Program database.
- Calculated Standardized Incidence Ratios (SIR) to compare SPM risk in eoCRC and loCRC patients to the general population.
- Analyzed SPM risk based on time since diagnosis, sex, race, income, and birth cohort.
Main Results:
- Individuals with eoCRC showed a 42% increased lifetime risk of SPM (SIR 1.42), unlike loCRC patients (SIR 1.00).
- Highest SPM risks were observed for small intestine, ureter, rectum, and colon cancers.
- SPM risk was higher in non-whites, those with lower income, and peaked within the first 5 years post-diagnosis (SIR 2.44).
Conclusions:
- Patients with eoCRC have a nearly 50% higher lifetime risk of developing SPM compared to the general population.
- The risk of SPM after eoCRC is elevated in the initial five years post-diagnosis.
- The incidence of SPM following eoCRC is increasing over time, indicating a growing public health concern.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Cancer Prevention
Some...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

